Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Alexis Kang"'
Autor:
Mark Haas, Xiaohai Zhang, Helen Pizzo, Stanley C. Jordan, Justin Steggerda, I. Kim, Elaine S. Kamil, Dechu Puliyanda, Alexis Kang
Publikováno v:
Pediatric transplantation. 21(8)
Preformed and de novo donor specific antibodies (pDSA and dnDSA) are risk factors for ABMR. This study compares the effects of pDSA vs dnDSA in pediatric kidney transplant recipients. Sixteen pediatric patients with biopsy-proven ABMR were evaluated.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5cbcb0655691ecd58ee8d63b6b5da91
https://pubmed.ncbi.nlm.nih.gov/29090853
https://pubmed.ncbi.nlm.nih.gov/29090853
Autor:
Joe Kahwaji, Erik G. Larsson, Mark Haas, Gunnar Tufveson, Shili Ge, Christian Kjellman, Stanley C. Jordan, Torsten Eich, Lars Bäckman, Jua Choi, Alice Peng, Sofia Järnum, Cynthia C. Nast, Lars Wennberg, Britt-Marie Eriksson, Mieko Toyoda, Alexis Kang, Xiaohai Zhang, Mats Bengtsson, Torbjörn Lundgren, Sabrina Louie, Ashley Vo, Tomas Lorant, Kathryn J. Wood, Rafael Villicana, Lena Winstedt
Publikováno v:
The New England journal of medicine. 377(5)
BACKGROUND Donor-specific antibodies create an immunologic barrier to transplantation. Current therapies to modify donor-specific antibodies are limited and ineffective in the most highly HLA-sensitized patients. The IgG-degrading enzyme derived from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09580f2e5712237b92e270f88b291c8c
https://pubmed.ncbi.nlm.nih.gov/29352605
https://pubmed.ncbi.nlm.nih.gov/29352605
Autor:
Ashley Vo, Andrew S. Klein, Vinay Sundaram, Tsuyoshi Todo, Alagappan Annamalai, S.-H. Pan, Nicholas N. Nissen, Justin Steggerda, I. Kim, Alexis Kang, Stanley C. Jordan
Publikováno v:
Transplantation proceedings. 49(6)
Background Preformed donor-specific human leukocyte antigen antibodies (DSAs) in patients undergoing simultaneous liver and kidney transplantation (SLKT) are an independent risk factor for poorer patient and renal allograft survival. The outcomes of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70bccff345164d7f1214b8dcd005d026
https://pubmed.ncbi.nlm.nih.gov/28736013
https://pubmed.ncbi.nlm.nih.gov/28736013
Autor:
Olivier Aubert, Alexis Kang, Stanley C. Jordan, Mieko Toyoda, Mark Haas, Irene Kim, Dechu Puliyanda, Jua Choi, Sabrina Louie, Ashley Vo, Alice Peng, Joe Kahwaji, Nancy L. Reinsmoen, Alexandre Loupy
Publikováno v:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 17(9)
Extending the functional integrity of renal allografts is the primary goal of transplant medicine. The development of donor-specific antibodies (DSAs) posttransplantation leads to chronic active antibody-mediated rejection (cAMR) and transplant glome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bc2418221a56c87616a2f6e26465a4a
https://pubmed.ncbi.nlm.nih.gov/28199785
https://pubmed.ncbi.nlm.nih.gov/28199785
Autor:
James Mirocha, Odette A. Galera, Alexis Kang, Stanley C. Jordan, Elaine S. Kamil, Ashley Vo, I. Kim, Dechu Puliyanda, Jua Choi, Sabrina Louie, J. Louis Cohen, Mieko Toyoda, Mitasha Patel
Publikováno v:
Transplantation
BACKGROUND: Studies show that alemtuzumab, a potent lymphocyte-depleting agent, is well tolerated in pediatric renal transplantation. We report on the use of alemtuzumab induction in highly HLA sensitized (HS) pediatric kidney transplant patients. ME
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::402662793a11d4659ba9e1cf0b211ae5
https://pubmed.ncbi.nlm.nih.gov/27495773
https://pubmed.ncbi.nlm.nih.gov/27495773
Autor:
Jua Choi, Helen Pizzo, J. Louis Cohen, Mark Haas, Stanley C. Jordan, Elaine S. Kamil, Justin Steggerda, James Mirocha, I. Kim, Dechu Puliyanda, Sabrina Louie, Alexis Kang, Ashley Vo
Publikováno v:
Pediatric Transplantation. 21:e13042
ABMR remains a significant concern for early graft loss, especially for those who are HS against HLA antigens. We sought to determine the risk factors leading to ABMR in HS pediatric kidney transplant recipients. From January 2009 to December 2015, 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cc7fb940ed0621f5de8fa1fe28e1ef5
https://doi.org/10.1111/petr.13042
https://doi.org/10.1111/petr.13042
Autor:
Kim, Irene K., Jua Choi, Vo, Ashley A., Alexis Kang, Patel, Mitasha, Toyoda, Mieko, Mirocha, James, Kamil, Elaine S., Cohen, J. Louis, Louie, Sabrina, Galera, Odette, Jordan, Stanley C., Puliyanda, Dechu P.
Publikováno v:
Transplantation; Apr2017, Vol. 101 Issue 4, p883-889, 7p